查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1435118

心房中膈缺损症市场：依症状、依应用分类 - 2024-2030 年全球预测

Atrial Septal Defect Market by Symptoms (Dyspnea, Fatigue, Frequent Respiratory Infections), Application (Ambulatory Surgical Centers, Hospitals, Specialty Clinics) - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

心房中膈缺损症市场规模预计2023年为57亿美元，预计2024年将达60.5亿美元，2030年将达到87.3亿美元，复合年增长率为6.29%。

心房中膈缺损症的全球市场

主要市场统计
基准年[2023] 57亿美元
预测年份 [2024] 60.5亿美元
预测年份 [2030] 87.3亿美元
复合年增长率（%） 6.29%
心房中隔缺损市场-IMG1

FPNV定位矩阵

FPNV定位矩阵对于评估心房中膈缺损症市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对心房中膈缺损症市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解：

1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2-市场开拓：我们深入研究利润丰厚的新兴市场并分析其在成熟细分市场的渗透率。

3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1-心房中膈缺损症市场的市场规模与预测是多少？

2-在心房中膈缺损症市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些？

3-心房中膈缺损症市场的技术趋势和法律规范是什么？

4-心房中膈缺损症市场主要供应商的市场占有率是多少？

5-进入心房中膈缺损症市场适合的型态和策略手段有哪些？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 遗传性心臟疾病盛行率上升
      • 政府和公共机构扩大对心房中膈缺损症的认知宣传活动
      • 心臟MRI检查简介
    • 抑制因素
      • 经皮中隔缺损封堵术的解剖学限制
    • 机会
      • 先天性心臟疾病治疗技术进展
      • 政府对 ASD 治疗给予优惠报销
    • 任务
      • ASD 手术期间的併发症和副作用
  • 市场区隔分析
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第六章心房中膈缺损症市场（依症状）

  • 呼吸困难
  • 不适
  • 频繁呼吸道感染疾病
  • 心悸
  • 腿和脚肿胀

第七章心房中膈缺损症市场：依应用分类

  • 门诊手术中心
  • 医院
  • 专科诊所

第八章 北美和南美心房中膈缺损症

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太心房中膈缺损症市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲心房中膈缺损症

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析：主要企业
  • 主要企业竞争情境分析

第12章竞争产品组合

  • 主要公司简介
    • Abbott Laboratories
    • Asklepion Pharmaceuticals, LLC
    • AtriCure, Inc
    • Carag AG
    • GE HealthCare Technologies, Inc.
    • Johnson & Johnson Services, Inc.
    • Lepu Medical Technology（Beijing）Co., Ltd
    • Lifetech Scientific
    • Medtronic PLC
    • Occlutech GmbH
    • Siemens AG
    • WL Gore & Associates, Inc.
  • 主要产品系列

第十三章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-CA17E905E9D5

[189 Pages Report] The Atrial Septal Defect Market size was estimated at USD 5.70 billion in 2023 and expected to reach USD 6.05 billion in 2024, at a CAGR 6.29% to reach USD 8.73 billion by 2030.

Global Atrial Septal Defect Market

KEY MARKET STATISTICS
Base Year [2023] USD 5.70 billion
Estimated Year [2024] USD 6.05 billion
Forecast Year [2030] USD 8.73 billion
CAGR (%) 6.29%
Atrial Septal Defect Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Atrial Septal Defect Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Atrial Septal Defect Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Atrial Septal Defect Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Asklepion Pharmaceuticals, LLC, AtriCure, Inc, Carag AG, GE HealthCare Technologies, Inc., Johnson & Johnson Services, Inc., Lepu Medical Technology (Beijing) Co., Ltd, Lifetech Scientific, Medtronic PLC, Occlutech GmbH, Siemens AG, and W. L. Gore & Associates, Inc..

Market Segmentation & Coverage

This research report categorizes the Atrial Septal Defect Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Symptoms
    • Dyspnea
    • Fatigue
    • Frequent Respiratory Infections
    • Heart Palpitations
    • Swelling of Legs & Feet
  • Application
    • Ambulatory Surgical Centers
    • Hospitals
    • Specialty Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Atrial Septal Defect Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Atrial Septal Defect Market?

3. What are the technology trends and regulatory frameworks in the Atrial Septal Defect Market?

4. What is the market share of the leading vendors in the Atrial Septal Defect Market?

5. Which modes and strategic moves are suitable for entering the Atrial Septal Defect Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Atrial Septal Defect Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalences of genetic heart disorders
      • 5.1.1.2. Growing awareness campaigns regarding atrial septal defects by government and public organizations
      • 5.1.1.3. Adoption of cardiac MRI procedures
    • 5.1.2. Restraints
      • 5.1.2.1. Anatomical limitations to percutaneous ASD closure
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement in the treatment of congenital heart diseases
      • 5.1.3.2. Favorable government reimbursements for ASD treatment
    • 5.1.4. Challenges
      • 5.1.4.1. Complication and side effects during ASD surgeries
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Atrial Septal Defect Market, by Symptoms

  • 6.1. Introduction
  • 6.2. Dyspnea
  • 6.3. Fatigue
  • 6.4. Frequent Respiratory Infections
  • 6.5. Heart Palpitations
  • 6.6. Swelling of Legs & Feet

7. Atrial Septal Defect Market, by Application

  • 7.1. Introduction
  • 7.2. Ambulatory Surgical Centers
  • 7.3. Hospitals
  • 7.4. Specialty Clinics

8. Americas Atrial Septal Defect Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Atrial Septal Defect Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Atrial Septal Defect Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. Abbott Laboratories
    • 12.1.2. Asklepion Pharmaceuticals, LLC
    • 12.1.3. AtriCure, Inc
    • 12.1.4. Carag AG
    • 12.1.5. GE HealthCare Technologies, Inc.
    • 12.1.6. Johnson & Johnson Services, Inc.
    • 12.1.7. Lepu Medical Technology (Beijing) Co., Ltd
    • 12.1.8. Lifetech Scientific
    • 12.1.9. Medtronic PLC
    • 12.1.10. Occlutech GmbH
    • 12.1.11. Siemens AG
    • 12.1.12. W. L. Gore & Associates, Inc.
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. ATRIAL SEPTAL DEFECT MARKET RESEARCH PROCESS
  • FIGURE 2. ATRIAL SEPTAL DEFECT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ATRIAL SEPTAL DEFECT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ATRIAL SEPTAL DEFECT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ATRIAL SEPTAL DEFECT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ATRIAL SEPTAL DEFECT MARKET DYNAMICS
  • FIGURE 7. ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2023 VS 2030 (%)
  • FIGURE 8. ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ATRIAL SEPTAL DEFECT MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 20. ATRIAL SEPTAL DEFECT MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ATRIAL SEPTAL DEFECT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ATRIAL SEPTAL DEFECT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 6. ATRIAL SEPTAL DEFECT MARKET SIZE, BY DYSPNEA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ATRIAL SEPTAL DEFECT MARKET SIZE, BY FATIGUE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ATRIAL SEPTAL DEFECT MARKET SIZE, BY FREQUENT RESPIRATORY INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ATRIAL SEPTAL DEFECT MARKET SIZE, BY HEART PALPITATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ATRIAL SEPTAL DEFECT MARKET SIZE, BY SWELLING OF LEGS & FEET, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. ATRIAL SEPTAL DEFECT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. ATRIAL SEPTAL DEFECT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ATRIAL SEPTAL DEFECT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ATRIAL SEPTAL DEFECT MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 102. ATRIAL SEPTAL DEFECT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 103. ATRIAL SEPTAL DEFECT MARKET LICENSE & PRICING